Legal status · United States
Is ANP legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. ANP is not an approved medicine in the United States; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile.
ANP in the United States at a glance
| Classification | Not approved |
|---|---|
| Note | No ANP or carperitide product was found in Drugs@FDA on 11 September 2026. The natriuretic peptide the FDA did approve is nesiritide, a recombinant B-type natriuretic peptide, and that product is now discontinued. |
| FDA approval status | Not FDA approved. No ANP or carperitide product was returned by the Drugs@FDA query on 11 September 2026. Carperitide is described in the clinical literature as in use for acute heart failure in Japan; this site did not verify that approval with the Japanese regulator and does not state its date or terms. |
| Human studies cited | 6 of 7 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the ANP profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing ANP is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What ANP is
The hormone the heart releases when its chambers stretch, and the reason the heart counts as an endocrine organ. Its recombinant form, carperitide, is used for acute heart failure in Japan; a 2025 meta-analysis of 9 studies found higher in-hospital mortality in carperitide-treated patients when randomised and propensity-matched studies were pooled.
Atrial natriuretic peptide is a 28 amino acid peptide, sequence SLRRSSCFGGRMDRIGAQSGLGCNSFRY, released from atrial cells when the chamber wall is stretched. It makes the kidney excrete sodium and water, relaxes blood vessels and opposes the renin-angiotensin system.
Mechanism: In humans, ANP binds NPR-A (gene NPR1), a particulate guanylyl cyclase, raising cyclic GMP in vascular smooth muscle and kidney tubule cells. The results are natriuresis, diuresis and vasodilation, plus suppression of renin and aldosterone.
Regulatory history: Not FDA approved. No ANP or carperitide product was returned by the Drugs@FDA query on 11 September 2026. Carperitide is described in the clinical literature as in use for acute heart failure in Japan; this site did not verify that approval with the Japanese regulator and does not state its date or terms.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for ANP at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
ANP in other countries
Frequently asked questions
Is ANP legal in the United States?
No. ANP is not an approved medicine in the United States; its classification is "Not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 6 human studies are cited on its profile. Note: No ANP or carperitide product was found in Drugs@FDA on 11 September 2026. The natriuretic peptide the FDA did approve is nesiritide, a recombinant B-type natriuretic peptide, and that product is now discontinued.
Can I buy ANP in the United States?
No approved product exists to buy. In the United States ANP is classified as "Not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors. Note: No ANP or carperitide product was found in Drugs@FDA on 11 September 2026. The natriuretic peptide the FDA did approve is nesiritide, a recombinant B-type natriuretic peptide, and that product is now discontinued.
Is ANP FDA approved?
No. FDA status: Not FDA approved. No ANP or carperitide product was returned by the Drugs@FDA query on 11 September 2026. Carperitide is described in the clinical literature as in use for acute heart failure in Japan; this site did not verify that approval with the Japanese regulator and does not state its date or terms.. Current US classification: "Not approved". On the evidence, 6 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for ANP live on its compound profile.
ANP profileThis page is general information about the regulatory status of ANP in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.